Search research articles
Contact Us
Filters
Showing results (121-130 of 167) with videos related to
Page
of 17
Sort By:
Molecular Endocrinology (Baltimore, Md.)
|
February 14, 2006
Socs2 and elf5 mediate prolactin-induced mammary gland development
Jessica Harris, Prudence M Stanford, Kate Sutherland, et al.
Cell Genomics
|
November 29, 2023
Three-dimensional genome architecture coordinates key regulators of lineage specification in mammary epithelial cells
Michael J G Milevskiy, Hannah D Coughlan, Serena R Kane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2022
VERONICA: Randomized Phase II Study of Fulvestrant and Venetoclax in ER-Positive Metastatic Breast Cancer Post-CDK4/6 Inhibitors - Efficacy, Safety, and Biomarker Results
Geoffrey J Lindeman, Tharu M Fernando, Rebecca Bowen, et al.
Genes & Development
|
March 5, 2008
The Ets transcription factor Elf5 specifies mammary alveolar cell fate
Samantha R Oakes, Matthew J Naylor, Marie-Liesse Asselin-Labat, et al.
Molecular and Cellular Biology
|
September 21, 2011
Gata-3 negatively regulates the tumor-initiating capacity of mammary luminal progenitor cells and targets the putative tumor suppressor caspase-14
Marie-Liesse Asselin-Labat, Kate D Sutherland, François Vaillant, et al.
Nature Communications
|
November 27, 2021
Mammary tumour cells remodel the bone marrow vascular microenvironment to support metastasis
Raymond K H Yip, Joel S Rimes, Bianca D Capaldo, et al.
Science Translational Medicine
|
June 9, 2017
Combined immune checkpoint blockade as a therapeutic strategy for <i>BRCA1</i>-mutated breast cancer
Emma Nolan, Peter Savas, Antonia N Policheni, et al.
NPJ Breast Cancer
|
August 15, 2023
Combined PARP and WEE1 inhibition triggers anti-tumor immune response in BRCA1/2 wildtype triple-negative breast cancer
Zhi Ling Teo, Mark J O'Connor, Stephanie Versaci, et al.
Molecular Biology of the Cell
|
March 18, 2011
An autocrine TGF-beta/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition
Philip A Gregory, Cameron P Bracken, Eric Smith, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 20, 2011
Sensitization of BCL-2-expressing breast tumors to chemotherapy by the BH3 mimetic ABT-737
Samantha R Oakes, François Vaillant, Elgene Lim, et al.
Page
of 17
Search research articles
Search
Showing results (121-130 of 167) with videos related to
Sort By:
Page
of 17
Molecular Endocrinology (Baltimore, Md.)
|
February 14, 2006
Socs2 and elf5 mediate prolactin-induced mammary gland development
Jessica Harris, Prudence M Stanford, Kate Sutherland, et al.
Cell Genomics
|
November 29, 2023
Three-dimensional genome architecture coordinates key regulators of lineage specification in mammary epithelial cells
Michael J G Milevskiy, Hannah D Coughlan, Serena R Kane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2022
VERONICA: Randomized Phase II Study of Fulvestrant and Venetoclax in ER-Positive Metastatic Breast Cancer Post-CDK4/6 Inhibitors - Efficacy, Safety, and Biomarker Results
Geoffrey J Lindeman, Tharu M Fernando, Rebecca Bowen, et al.
Genes & Development
|
March 5, 2008
The Ets transcription factor Elf5 specifies mammary alveolar cell fate
Samantha R Oakes, Matthew J Naylor, Marie-Liesse Asselin-Labat, et al.
Molecular and Cellular Biology
|
September 21, 2011
Gata-3 negatively regulates the tumor-initiating capacity of mammary luminal progenitor cells and targets the putative tumor suppressor caspase-14
Marie-Liesse Asselin-Labat, Kate D Sutherland, François Vaillant, et al.
Nature Communications
|
November 27, 2021
Mammary tumour cells remodel the bone marrow vascular microenvironment to support metastasis
Raymond K H Yip, Joel S Rimes, Bianca D Capaldo, et al.
Science Translational Medicine
|
June 9, 2017
Combined immune checkpoint blockade as a therapeutic strategy for <i>BRCA1</i>-mutated breast cancer
Emma Nolan, Peter Savas, Antonia N Policheni, et al.
NPJ Breast Cancer
|
August 15, 2023
Combined PARP and WEE1 inhibition triggers anti-tumor immune response in BRCA1/2 wildtype triple-negative breast cancer
Zhi Ling Teo, Mark J O'Connor, Stephanie Versaci, et al.
Molecular Biology of the Cell
|
March 18, 2011
An autocrine TGF-beta/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition
Philip A Gregory, Cameron P Bracken, Eric Smith, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 20, 2011
Sensitization of BCL-2-expressing breast tumors to chemotherapy by the BH3 mimetic ABT-737
Samantha R Oakes, François Vaillant, Elgene Lim, et al.
Page
of 17